Lineage Cell Therapeutics In shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $35k | 24k | 1.48 |
| 2023-09-30 | $30k | 26k | 1.18 |
| 2023-06-30 | $36k | 26k | 1.41 |
| 2023-03-31 | $39k | 26k | 1.50 |
| 2022-12-31 | $30k | 26k | 1.17 |
| 2022-09-30 | $78k | 69k | 1.12 |
| 2022-06-30 | $64k | 41k | 1.57 |
| 2021-12-31 | $747k | 305k | 2.45 |